Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Dallas, TX
SEC filing record 1 source field available
Fiscal year end
31 December
Lantern Pharma Inc. has filed 249 SEC EDGAR filings since 14 Jan 2019

SEC filing history

Showing 226-249 of 249 matching filings.

Per page
25
Current page
10
3

3 filing

Filing date
10 Jun 2020
Reporting date
10 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

3 filing

Filing date
10 Jun 2020
Reporting date
10 Jun 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
CERT File 001-39318

8A CERT

Filing date
08 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
08 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-A12B File 001-39318

FOR REGISTRATION OF CERTAIN CLASSES

Filing date
08 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-237714

AMENDMENT NO. 3 TO FORM S-1

Filing date
08 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
02 Jun 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
29 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
22 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
22 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
FWP File 333-237714

FREE WRITING PROSPECTUS

Filing date
19 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-237714

AMENDMENT NO. 2 TO FORM S-1

Filing date
19 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
12 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1/A File 333-237714

AMENDMENT NO. 1 TO FORM S-1

Filing date
12 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
01 May 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
16 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-1 File 333-237714

REGISTRATION STATEMENT

Filing date
16 Apr 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SEC STAFF LETTER

SEC STAFF LETTER filing

Filing date
21 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
21 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRSLTR

DRSLTR filing

Filing date
24 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DRS File 377-03009

DRS filing

Filing date
24 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-335101

D filing

Filing date
18 Mar 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-330392

D filing

Filing date
14 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .